Transcriptomic analysis of atopic dermatitis in African Americans is characterized by Th2/Th17-centered cutaneous immune activation

Abstract Atopic dermatitis (AD) often presents more severely in African Americans (AAs) and with greater involvement of extensor areas. To investigate immune signatures of AD in AAs with moderate to severe pruritus, lesional and non-lesional punch biopsies were taken from AA patients along with age-...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Shannon Wongvibulsin, Nishadh Sutaria, Suraj Kannan, Martin Prince Alphonse, Micah Belzberg, Kyle A. Williams, Isabelle D. Brown, Justin Choi, Youkyung Sophie Roh, Thomas Pritchard, Raveena Khanna, Amarachi C. Eseonu, Jaroslaw Jedrych, Carly Dillen, Madan M. Kwatra, Anna L. Chien, Nathan Archer, Luis A. Garza, Xinzhong Dong, Sewon Kang, Shawn G. Kwatra
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
R
Q
Acceso en línea:https://doaj.org/article/82598be293ef423d9b1d4aa391ce6e81
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:82598be293ef423d9b1d4aa391ce6e81
record_format dspace
spelling oai:doaj.org-article:82598be293ef423d9b1d4aa391ce6e812021-12-02T15:00:40ZTranscriptomic analysis of atopic dermatitis in African Americans is characterized by Th2/Th17-centered cutaneous immune activation10.1038/s41598-021-90105-w2045-2322https://doaj.org/article/82598be293ef423d9b1d4aa391ce6e812021-05-01T00:00:00Zhttps://doi.org/10.1038/s41598-021-90105-whttps://doaj.org/toc/2045-2322Abstract Atopic dermatitis (AD) often presents more severely in African Americans (AAs) and with greater involvement of extensor areas. To investigate immune signatures of AD in AAs with moderate to severe pruritus, lesional and non-lesional punch biopsies were taken from AA patients along with age-, race-, and sex-matched controls. Histology of lesional skin showed psoriasiform dermatitis and spongiotic dermatitis, suggesting both Th2 and Th17 activity. Gene Set Variation Analysis showed upregulation of Th2 and Th17 pathways in both lesional versus non-lesional and lesional versus control (p < 0.01), while Th1 and Th22 upregulation were observed in lesional versus control (p < 0.05). Evidence for a broad immune signature also was supported by upregulated Th1 and Th22 pathways, and clinically may represent greater severity of AD in AA. Furthermore, population-level analysis of data from TriNetX, a global federated health research network, revealed that AA AD patients had higher values for CRP, ferritin, and blood eosinophils compared to age-, sex-, and race-matched controls as well as white AD patients, suggesting broad systemic inflammation. Therefore, AA AD patients may feature broader immune activation than previously thought and may derive benefit from systemic immunomodulating therapies that modulate key drivers of multiple immune pathways.Shannon WongvibulsinNishadh SutariaSuraj KannanMartin Prince AlphonseMicah BelzbergKyle A. WilliamsIsabelle D. BrownJustin ChoiYoukyung Sophie RohThomas PritchardRaveena KhannaAmarachi C. EseonuJaroslaw JedrychCarly DillenMadan M. KwatraAnna L. ChienNathan ArcherLuis A. GarzaXinzhong DongSewon KangShawn G. KwatraNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-11 (2021)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Shannon Wongvibulsin
Nishadh Sutaria
Suraj Kannan
Martin Prince Alphonse
Micah Belzberg
Kyle A. Williams
Isabelle D. Brown
Justin Choi
Youkyung Sophie Roh
Thomas Pritchard
Raveena Khanna
Amarachi C. Eseonu
Jaroslaw Jedrych
Carly Dillen
Madan M. Kwatra
Anna L. Chien
Nathan Archer
Luis A. Garza
Xinzhong Dong
Sewon Kang
Shawn G. Kwatra
Transcriptomic analysis of atopic dermatitis in African Americans is characterized by Th2/Th17-centered cutaneous immune activation
description Abstract Atopic dermatitis (AD) often presents more severely in African Americans (AAs) and with greater involvement of extensor areas. To investigate immune signatures of AD in AAs with moderate to severe pruritus, lesional and non-lesional punch biopsies were taken from AA patients along with age-, race-, and sex-matched controls. Histology of lesional skin showed psoriasiform dermatitis and spongiotic dermatitis, suggesting both Th2 and Th17 activity. Gene Set Variation Analysis showed upregulation of Th2 and Th17 pathways in both lesional versus non-lesional and lesional versus control (p < 0.01), while Th1 and Th22 upregulation were observed in lesional versus control (p < 0.05). Evidence for a broad immune signature also was supported by upregulated Th1 and Th22 pathways, and clinically may represent greater severity of AD in AA. Furthermore, population-level analysis of data from TriNetX, a global federated health research network, revealed that AA AD patients had higher values for CRP, ferritin, and blood eosinophils compared to age-, sex-, and race-matched controls as well as white AD patients, suggesting broad systemic inflammation. Therefore, AA AD patients may feature broader immune activation than previously thought and may derive benefit from systemic immunomodulating therapies that modulate key drivers of multiple immune pathways.
format article
author Shannon Wongvibulsin
Nishadh Sutaria
Suraj Kannan
Martin Prince Alphonse
Micah Belzberg
Kyle A. Williams
Isabelle D. Brown
Justin Choi
Youkyung Sophie Roh
Thomas Pritchard
Raveena Khanna
Amarachi C. Eseonu
Jaroslaw Jedrych
Carly Dillen
Madan M. Kwatra
Anna L. Chien
Nathan Archer
Luis A. Garza
Xinzhong Dong
Sewon Kang
Shawn G. Kwatra
author_facet Shannon Wongvibulsin
Nishadh Sutaria
Suraj Kannan
Martin Prince Alphonse
Micah Belzberg
Kyle A. Williams
Isabelle D. Brown
Justin Choi
Youkyung Sophie Roh
Thomas Pritchard
Raveena Khanna
Amarachi C. Eseonu
Jaroslaw Jedrych
Carly Dillen
Madan M. Kwatra
Anna L. Chien
Nathan Archer
Luis A. Garza
Xinzhong Dong
Sewon Kang
Shawn G. Kwatra
author_sort Shannon Wongvibulsin
title Transcriptomic analysis of atopic dermatitis in African Americans is characterized by Th2/Th17-centered cutaneous immune activation
title_short Transcriptomic analysis of atopic dermatitis in African Americans is characterized by Th2/Th17-centered cutaneous immune activation
title_full Transcriptomic analysis of atopic dermatitis in African Americans is characterized by Th2/Th17-centered cutaneous immune activation
title_fullStr Transcriptomic analysis of atopic dermatitis in African Americans is characterized by Th2/Th17-centered cutaneous immune activation
title_full_unstemmed Transcriptomic analysis of atopic dermatitis in African Americans is characterized by Th2/Th17-centered cutaneous immune activation
title_sort transcriptomic analysis of atopic dermatitis in african americans is characterized by th2/th17-centered cutaneous immune activation
publisher Nature Portfolio
publishDate 2021
url https://doaj.org/article/82598be293ef423d9b1d4aa391ce6e81
work_keys_str_mv AT shannonwongvibulsin transcriptomicanalysisofatopicdermatitisinafricanamericansischaracterizedbyth2th17centeredcutaneousimmuneactivation
AT nishadhsutaria transcriptomicanalysisofatopicdermatitisinafricanamericansischaracterizedbyth2th17centeredcutaneousimmuneactivation
AT surajkannan transcriptomicanalysisofatopicdermatitisinafricanamericansischaracterizedbyth2th17centeredcutaneousimmuneactivation
AT martinprincealphonse transcriptomicanalysisofatopicdermatitisinafricanamericansischaracterizedbyth2th17centeredcutaneousimmuneactivation
AT micahbelzberg transcriptomicanalysisofatopicdermatitisinafricanamericansischaracterizedbyth2th17centeredcutaneousimmuneactivation
AT kyleawilliams transcriptomicanalysisofatopicdermatitisinafricanamericansischaracterizedbyth2th17centeredcutaneousimmuneactivation
AT isabelledbrown transcriptomicanalysisofatopicdermatitisinafricanamericansischaracterizedbyth2th17centeredcutaneousimmuneactivation
AT justinchoi transcriptomicanalysisofatopicdermatitisinafricanamericansischaracterizedbyth2th17centeredcutaneousimmuneactivation
AT youkyungsophieroh transcriptomicanalysisofatopicdermatitisinafricanamericansischaracterizedbyth2th17centeredcutaneousimmuneactivation
AT thomaspritchard transcriptomicanalysisofatopicdermatitisinafricanamericansischaracterizedbyth2th17centeredcutaneousimmuneactivation
AT raveenakhanna transcriptomicanalysisofatopicdermatitisinafricanamericansischaracterizedbyth2th17centeredcutaneousimmuneactivation
AT amarachiceseonu transcriptomicanalysisofatopicdermatitisinafricanamericansischaracterizedbyth2th17centeredcutaneousimmuneactivation
AT jaroslawjedrych transcriptomicanalysisofatopicdermatitisinafricanamericansischaracterizedbyth2th17centeredcutaneousimmuneactivation
AT carlydillen transcriptomicanalysisofatopicdermatitisinafricanamericansischaracterizedbyth2th17centeredcutaneousimmuneactivation
AT madanmkwatra transcriptomicanalysisofatopicdermatitisinafricanamericansischaracterizedbyth2th17centeredcutaneousimmuneactivation
AT annalchien transcriptomicanalysisofatopicdermatitisinafricanamericansischaracterizedbyth2th17centeredcutaneousimmuneactivation
AT nathanarcher transcriptomicanalysisofatopicdermatitisinafricanamericansischaracterizedbyth2th17centeredcutaneousimmuneactivation
AT luisagarza transcriptomicanalysisofatopicdermatitisinafricanamericansischaracterizedbyth2th17centeredcutaneousimmuneactivation
AT xinzhongdong transcriptomicanalysisofatopicdermatitisinafricanamericansischaracterizedbyth2th17centeredcutaneousimmuneactivation
AT sewonkang transcriptomicanalysisofatopicdermatitisinafricanamericansischaracterizedbyth2th17centeredcutaneousimmuneactivation
AT shawngkwatra transcriptomicanalysisofatopicdermatitisinafricanamericansischaracterizedbyth2th17centeredcutaneousimmuneactivation
_version_ 1718389148332589056